About
Technology
Issues
FAQ
Links
Official Page
Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.